Lin C. Clinical Evaluation of Bexagliflozin and Other SGLT2 Inhibitors for Type 2 Diabetes Management. HSET [Internet]. 2023 Dec. 29 [cited 2026 Aug. 1];74:1576-80. Available from: https://drpress.org/ojs/index.php/HSET/article/view/15871